Low-molecular weight mannogalactofucans prevent herpes simplex virus type 1 infection via activation of Toll-like receptor 2

Int J Biol Macromol. 2017 Oct:103:286-293. doi: 10.1016/j.ijbiomac.2017.05.060. Epub 2017 May 15.

Abstract

Low-molecular-weight mannogalactofucans (LMMGFs, <4000g/mol) were prepared by the enzymatic degradation of Undaria pinnatifida sporophyll galactofucan (MF) and evaluated or their antiviral activities and underlying action mechanisms against herpes simplex virus type 1 (HSV-1). The 50% inhibitory concentrations (IC50) of LMMGFs and MF were 2.64 and 2.42μg/mL, respectively. LMMGFs inhibited the viral entry on the host cell surface and also exhibited inhibitory activity directly against viral particles, as observed in a virucidal assay. LMMGFs dose-dependently enhanced the mRNA expression of Toll-like receptor 2 (TLR2) and stimulated the phosphorylation of Akt and JNK in Vero cells. These results clearly demonstrated that LMMGFs use TLR2 as their receptor, preventing HSV-1 infection on the host cell surface and antagonizing viral adsorption via TLR2 pathway activation in Vero cells.

Keywords: Antiviral activity; Mannogalactofucans; Toll-like receptor 2.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Chlorocebus aethiops
  • Galactose / chemistry*
  • Galactose / pharmacology*
  • Herpes Simplex / metabolism
  • Herpes Simplex / prevention & control*
  • Herpesvirus 1, Human / drug effects*
  • Molecular Weight
  • Solubility
  • Toll-Like Receptor 2 / metabolism*
  • Vero Cells

Substances

  • Antiviral Agents
  • Toll-Like Receptor 2
  • Galactose